Epimede

Epimède SA, based in Liège, Belgium, is a venture capital firm specializing in early-stage investments, particularly in the biotechnology, healthcare, and medical device sectors. The firm has made notable investments in companies such as Imcyse, Endo Tools Therapeutics, and Ncardia. Epimède aims to support innovative technologies and solutions that can have a significant impact on their respective industries. For instance, Imcyse, a pharmaceutical and therapeutics company, secured $25 million in a funding round that included participation from notable investors like Pfizer and Biogenosis. Similarly, Endo Tools Therapeutics, a medical device company, raised $5 million with support from investors including SFPI-FPIM and Chagral Invest. Ncardia, another biotechnology and pharmaceutical firm, attracted $12 million in funding from partners such as Vesalius Biocapital Partners and InnovationQuarter. Epimède collaborates with various investment partners, including SFPI-FPIM and S.R.I.W., to co-invest in promising startups and foster growth and innovation in the healthcare and biotech sectors.